Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer
Abstract
Share and Cite
Melosky, B.; Cheema, P.; Agulnik, J.; Albadine, R.; Bebb, D.G.; Blais, N.; Burkes, R.; Butts, C.; Card, P.B.; Chan, A.M.Y.; et al. Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer. Curr. Oncol. 2018, 25, 317-328. https://doi.org/10.3747/co.25.4379
Melosky B, Cheema P, Agulnik J, Albadine R, Bebb DG, Blais N, Burkes R, Butts C, Card PB, Chan AMY, et al. Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer. Current Oncology. 2018; 25(5):317-328. https://doi.org/10.3747/co.25.4379
Chicago/Turabian StyleMelosky, B., P. Cheema, J. Agulnik, R. Albadine, D.G. Bebb, N. Blais, R. Burkes, C. Butts, P.B. Card, A.M.Y. Chan, and et al. 2018. "Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer" Current Oncology 25, no. 5: 317-328. https://doi.org/10.3747/co.25.4379